State Street’s Signify Health, Inc. SGFY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,211,844
Closed -$34.7M 4853
2022
Q4
$34.7M Buy
1,211,844
+55,184
+5% +$1.59M ﹤0.01% 1875
2022
Q3
$33.7M Buy
1,156,660
+226,154
+24% +$5.21M ﹤0.01% 1874
2022
Q2
$12.8M Buy
930,506
+61,611
+7% +$867K ﹤0.01% 2548
2022
Q1
$15.8M Buy
868,895
+32,138
+4% +$461K ﹤0.01% 2561
2021
Q4
$11.9M Buy
836,757
+136,654
+20% +$2.11M ﹤0.01% 2822
2021
Q3
$12.5M Buy
700,103
+268,522
+62% +$6.91M ﹤0.01% 2756
2021
Q2
$13.1M Buy
431,581
+285,827
+196% +$7.86M ﹤0.01% 2757
2021
Q1
$4.26M Buy
+145,754
New +$4.51M ﹤0.01% 3118

Other funds holding SGFY

State Street's SGFY Position: Q1 2023 in Review

State Street sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 1,211,844 shares — an estimated $34.7M sold.

State Street first reported a position in SGFY in Q1 2021 and held it in 8 quarters. The position peaked at $34.7M in Q4 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

  • State Street reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
  • State Street sold 1,211,844 Signify Health, Inc. shares in Q1 2023, an estimated $34.7M.
  • State Street first reported a position in Signify Health, Inc. in Q1 2021 and held it in 8 quarters.
  • State Street's Signify Health, Inc. position peaked at $34.7M in Q4 2022.
  • 5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on State Street's 13F filing for Q1 2023, filed 15 May 2023.